Allogeneic H-2 antigen expression is insufficient for tumor rejection

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Murine sarcoma I (SaI) tumor cells are a model for cancer research.
• Major histocompatibility complex (MHC) class I antigens play a crucial role in immune recognition and T cell responses.
• The H-2Kb antigen is a specific MHC class I allele found in certain mouse strains.

Purpose of the Study:

• To investigate whether stable expression of an allogeneic H-2Kb gene in SaI tumor cells could lead to rejection by the host immune system.
• To determine if the presence of an allogeneic MHC class I antigen on tumor cells is sufficient for inducing tumor rejection.

Main Methods:

• Transfection of SaI tumor cells with a cloned H-2Kb gene.
• Generation and characterization of stable transfectant clones (SKB clones) expressing H-2Kb.
• Assessment of susceptibility to cytotoxic T lymphocyte (CTL)-mediated lysis using H-2Kb-specific effector cells.
• Comparison of survival times in mice challenged with parental SaI cells versus H-2Kb-expressing transfectants.

Main Results:

• SKB clones stably expressed high levels of H-2Kb antigen, indistinguishable from the native form.
• SKB clones were resistant to lysis by H-2Kb-specific CTLs, including virus-specific effectors.
• Mice challenged with H-2Kb-expressing SaI cells showed similar survival times to those challenged with parental SaI cells.

Conclusions:

• Stable expression of an allogeneic H-2Kb antigen on SaI tumor cells does not render them susceptible to H-2Kb-specific CTL-mediated lysis.
• The presence of an allogeneic MHC class I antigen on the tumor cell surface is insufficient to induce rejection of the tumor in vivo.